On September 4, according to Russian media reports, the deputy director of the National Research Center for epidemiology and microbiology in gamaliya, Russia, said that the center is expected to obtain the civil circulation license of the new coronavirus vaccine from September 10 to 13, when it can start to vaccinate the public. < / P > < p > according to Russian satellite news agency, logunov said in an interview with “Russia 24” TV station: “we must go through the quality inspection of the Russian federal health and social development Supervision Bureau, and we will obtain the civil circulation license from the 10th to the 13th of this month, and then we can start to vaccinate the people.” < / P > < p > he pointed out that the vaccine will be distributed to medical institutions by the Russian Ministry of health. But he also said frankly that the production capacity of the center may not be able to produce the necessary quantity of vaccines, which may not meet the national demand. Therefore, large-scale production has been started on three platforms. < / P > < p > on August 11, the Russian Ministry of health registered the world’s first vaccine to prevent new coronavirus infection, which was jointly developed by the National Research Center of epidemiology and microbiology of gamaliya and the Russian direct investment fund. The vaccine was named “satellite-v”. Dmitriev, President of the Russian direct investment fund, said that the fund has received applications from more than 20 countries to buy 1 billion doses of vaccine. He also pointed out that Russia has agreed to produce vaccines in five countries, and the existing capacity will reach 500 million doses per year.